CONTEXT: Dietary factors may trigger or exacerbate the autoimmune disease process. OBJECTIVE: Our objective was to examine dietary glycemic index (GI) and glycemic load (GL) for association with islet autoimmunity (IA) development, and progression from IA to type 1 diabetes. DESIGN: The Diabetes Autoimmunity Study in the Young follows children at increased genetic type 1 diabetes risk. Diet is collected prospectively via a parent-reported food frequency questionnaire. SETTING: This was an observational study of children in the Denver area. PATIENTS: A total of 1776 Diabetes Autoimmunity Study in the Young children younger than 11.5 yr was included in the study. INTERVENTIONS: There were no interventions. MAIN OUTCOME MEASURES: IA, defined as the presence of autoantibodies to insulin, glutamic acid decarboxylase, or protein tyrosine phosphatase at two consecutive visits, or the presence of autoantibodies at one visit and diabetic on the next consecutive visit was determined. Type 1 diabetes was diagnosed by a physician. A total of 89 subjects developed IA, and 17 subsequently developed type 1 diabetes during follow-up. Our hypothesis was formulated after data collection. RESULTS: GI and GL were not associated with IA development. More rapid progression to type 1 diabetes in children with IA was associated with higher dietary GI (hazard ratio: 2.20; 95% confidence interval: 1.17-4.15) and marginally associated with GL (hazard ratio: 1.59; 95% confidence interval: 0.96-2.64) at the first IA-positive visit. CONCLUSIONS: Higher dietary GI and GL are not associated with IA development, but higher GI is associated with more rapid progression to type 1 diabetes in children with IA, perhaps due to increased demand on the beta-cell to release insulin. Further study is needed to confirm this finding and identify the underlying biological mechanism.
CONTEXT: Dietary factors may trigger or exacerbate the autoimmune disease process. OBJECTIVE: Our objective was to examine dietary glycemic index (GI) and glycemic load (GL) for association with islet autoimmunity (IA) development, and progression from IA to type 1 diabetes. DESIGN: The Diabetes Autoimmunity Study in the Young follows children at increased genetic type 1 diabetes risk. Diet is collected prospectively via a parent-reported food frequency questionnaire. SETTING: This was an observational study of children in the Denver area. PATIENTS: A total of 1776 Diabetes Autoimmunity Study in the Young children younger than 11.5 yr was included in the study. INTERVENTIONS: There were no interventions. MAIN OUTCOME MEASURES: IA, defined as the presence of autoantibodies to insulin, glutamic acid decarboxylase, or protein tyrosine phosphatase at two consecutive visits, or the presence of autoantibodies at one visit and diabetic on the next consecutive visit was determined. Type 1 diabetes was diagnosed by a physician. A total of 89 subjects developed IA, and 17 subsequently developed type 1 diabetes during follow-up. Our hypothesis was formulated after data collection. RESULTS: GI and GL were not associated with IA development. More rapid progression to type 1 diabetes in children with IA was associated with higher dietary GI (hazard ratio: 2.20; 95% confidence interval: 1.17-4.15) and marginally associated with GL (hazard ratio: 1.59; 95% confidence interval: 0.96-2.64) at the first IA-positive visit. CONCLUSIONS: Higher dietary GI and GL are not associated with IA development, but higher GI is associated with more rapid progression to type 1 diabetes in children with IA, perhaps due to increased demand on the beta-cell to release insulin. Further study is needed to confirm this finding and identify the underlying biological mechanism.
Authors: Alan Winston Barclay; Victoria Mary Flood; Jennie Cecile Brand-Miller; Paul Mitchell Journal: Public Health Nutr Date: 2007-10-24 Impact factor: 4.022
Authors: Angela D Liese; Mandy Schulz; Fang Fang; Thomas M S Wolever; Ralph B D'Agostino; Karen C Sparks; Elizabeth J Mayer-Davis Journal: Diabetes Care Date: 2005-12 Impact factor: 19.112
Authors: L Yu; D T Robles; N Abiru; P Kaur; M Rewers; K Kelemen; G S Eisenbarth Journal: Proc Natl Acad Sci U S A Date: 2000-02-15 Impact factor: 11.205
Authors: Dana Dabelea; Ralph B D'Agostino; Elizabeth J Mayer-Davis; David J Pettitt; Giuseppina Imperatore; Larry M Dolan; Catherine Pihoker; Teresa A Hillier; Santica M Marcovina; Barbara Linder; Andrea M Ruggiero; Richard F Hamman Journal: Diabetes Care Date: 2006-02 Impact factor: 19.112
Authors: Molly M Lamb; Brittni Frederiksen; Jennifer A Seifert; Miranda Kroehl; Marian Rewers; Jill M Norris Journal: Diabetologia Date: 2015-06-07 Impact factor: 10.122
Authors: Randi K Johnson; Lauren A Vanderlinden; Brian C DeFelice; Ulla Uusitalo; Jennifer Seifert; Sili Fan; Tessa Crume; Oliver Fiehn; Marian Rewers; Katerina Kechris; Jill M Norris Journal: Pediatr Diabetes Date: 2020-08-09 Impact factor: 4.866
Authors: Tom G Richardson; Daniel J M Crouch; Grace M Power; Fernanda Morales-Berstein; Emma Hazelwood; Si Fang; Yoonsu Cho; Jamie R J Inshaw; Catherine C Robertson; Carlo Sidore; Francesco Cucca; Steven S Rich; John A Todd; George Davey Smith Journal: Nat Commun Date: 2022-04-28 Impact factor: 17.694
Authors: Martha M Henze; Elizabeth A Bemis; Jennifer A Seifert; Randi K Johnson; Fran Dong; Marian Rewers; Jill M Norris Journal: J Nutr Sci Date: 2020-05-11
Authors: Oktay Kirak; Eugene Ke; Kevin Y Yang; Anna Schwarz; Lars Plate; Amy Nham; Justin R Abadejos; Anna Valencia; R Luke Wiseman; Kathy O Lui; Manching Ku Journal: Int J Mol Sci Date: 2020-08-11 Impact factor: 5.923